期刊文献+

拉米夫定联合安络化纤丸治疗乙型肝炎早期肝硬化26例

暂未订购
导出
摘要 目的:探讨拉米夫定联合安络化纤丸治疗乙型肝炎早期肝硬化的疗效。方法:选择52例乙型肝炎早期肝硬化患者,随机分为两组,治疗组26例,应用拉米夫定联合安络化纤丸治疗;对照组26例单用拉米夫定治疗。结果:治疗结束时,治疗组显效46.2%,总有效率88.5%;而对照组显效26.9%,总有效率57.7%。两组在显效率、总有效率方面差异有显著性。结论:拉米夫定联合安络化纤丸治疗乙型肝炎早期肝硬化疗效更佳。
机构地区 运城市第二医院
出处 《实用医技杂志》 2007年第34期4700-4701,共2页 Journal of Practical Medical Techniques
  • 相关文献

参考文献2

二级参考文献31

  • 1[2]Mast EE, Alter MJ. Epidemiology of viral hepatitis: an overview.Semin Virol , 1993,4: 273-283.
  • 2[3]Liaw YF, Leung N, Guan R, et al. Asian-Pacific consensus state ment on the management of chronic hepatitis B: An update for the Asian-Pacific consensus working parties on Hepatitis B. Gastroenterol Hepatol, 2003, 18: 239-245.
  • 3[4]Lai CL, Chien RN, Leung NWY,et al. Aone-year trial of lamivudine for chronic hepatitis B. N Eng1 J Med, 1998,339:61-68.
  • 4[8]The EASL Jury. EASL international consensus conference on hepatitis B. J Hepatol, 2003, 38: 523-540.
  • 5[9]Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology , 2001,34:1225-1241.
  • 6[10]Li LL, Chun TW,Yin ML, et al. Prophylactic lamivudine prevents hepatitis B reactivation and mortality in patients receiving immunosup pression and chemotherapy. Hepatology , 2000,32:1183-1190.
  • 7[11]Lok AS, McMahon BJ. Chronic hepatitis B. https://www, aasld. org/eweb.
  • 8[12]Liaw YF, Sung JJY, Chow WC, et al. Effects of lamivudine on disease progression and development of liver cancer in advanced chronic hepatitis B: a prospective double-blined placebo-controlled clinical trial. Hepatology, 2003,38 (suppl 1 ): 262A.
  • 9[13]De Jongh FE, Janssen HLA, De Man RA, et al. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology , 1992,103:1630-1635.
  • 10[14]Fontana RJ. Mangement of patients with decompensated HBV cirrhosis. Semin Liver Dis, 2003 ,23:89-100

共引文献14034

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部